Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.

McInnes IB, Ostor AJK, Mease PJ, Tillett W, Baraliakos X, de Vlam K, Bessette L, Lippe R, Maniccia A, Feng D, Gao T, Zueger P, Saffore C, Kato K, Song IH, Deodhar A

Open source

DOI
10.1136/rmdopen-2021-002049
Published
2022 Mar
Container
RMD open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2021-002049,
  title = {Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.},
  author = {McInnes IB and Ostor AJK and Mease PJ and Tillett W and Baraliakos X and de Vlam K and Bessette L and Lippe R and Maniccia A and Feng D and Gao T and Zueger P and Saffore C and Kato K and Song IH and Deodhar A},
  year = {2022},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2021-002049},
  url = {https://doi.org/10.1136/rmdopen-2021-002049}
}

RIS

TY  - JOUR
TI  - Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.
AU  - McInnes IB
AU  - Ostor AJK
AU  - Mease PJ
AU  - Tillett W
AU  - Baraliakos X
AU  - de Vlam K
AU  - Bessette L
AU  - Lippe R
AU  - Maniccia A
AU  - Feng D
AU  - Gao T
AU  - Zueger P
AU  - Saffore C
AU  - Kato K
AU  - Song IH
AU  - Deodhar A
PY  - 2022
JO  - RMD open
DO  - 10.1136/rmdopen-2021-002049
UR  - https://doi.org/10.1136/rmdopen-2021-002049
ER  - 

APA

IB, M., AJK, O., PJ, M., W, T., X, B., K, D. V., L, B., R, L., A, M., D, F., T, G., P, Z., C, S., K, K., IH, S., & A, D. (2022). Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.. RMD open. https://doi.org/10.1136/rmdopen-2021-002049

Source records